Whilst SMARCB1 remains the main genetic aberration that characterises ATRTs, it is now known that SMARCA4 mutations occur in a rare number of ATRT cases where SMARCB1 expression remains present [77–80]. This evidence concerns the gene SMARCA4 and atypical teratoid rhabdoid tumor.